retatrutide nash nonalcoholic steatohepatitis trial Pharmacotherapy for NASH: Current and emerging Drugs for Non-alcoholic Steatohepatitis (NASH): – What KOLs Revealed? Lilly's Retatrutide

GLP-1R signaling in the brain exerts antidepressive effects by improving cognitive processes, promoting neuroprotection and neurotransmitter release Patients suffering from depression are characterized by impaired neuronal activity and synaptic plasticity dysfunction, resulting in volumetric changes in brain regions which regulate emotions or the stress response such as the hippocampus and the prefrontal cortex

FAQs about GLP-1s Q: Will I need to take GLP-1 medicine forever

Your GP will review your current weight, BMI and any obesity-related health conditions to assess how much weight loss might be beneficial before conception

However, for outcomes that were non-significant across all analyses, current evidence remains inconclusive

As weight changes, progress may also need to be viewed beyond the bathroom scale

GLP-1 (glucagon-like peptide-1) helps regulate blood sugar, reduce appetite, and increase feelings of fullness, making it easier for patients to manage their weight